The report "Enteral
Feeding Formulas Market by Product (Polymeric, Monomeric,
Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application
(Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home
Care) - Global Forecast to 2020", The global Enteral Feeding Formulas Market is expected to reach USD 5.95 Billion by 2020.
This market was valued at USD 4.13 Billion in 2015 and is expected to grow at a
CAGR of 7.6% from 2015 to 2020
Browse 187
tables and 72 figures spread through 225 Pages and in-depth TOC on "Enteral Feeding Formulas Market”
http://www.marketsandmarkets.com/Market-Reports/enteral-feeding-formulas-market-74876393.html
Early buyers will receive 10% customization on this reports
http://www.marketsandmarkets.com/Market-Reports/enteral-feeding-formulas-market-74876393.html
Early buyers will receive 10% customization on this reports
The global Enteral Feeding Formulas Market is
estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during
the forecast period. The market is mainly driven by the rising incidences of
chronic diseases and disorders, the rapidly increasing geriatric population,
increasing healthcare expenditure, rising prevalence of preterm births, and
increasing demand for homecare.
The Enteral Feeding Formulas Market is segmented based on
product, stage, application, end user, and region. Based on products, the
market is segmented into standard and disease-specific formulas. The standard
formulas segment is further segmented into polymeric formulas and monomeric
formulas. Disease-specific formulas are further subdivided into diabetic,
renal, hepatic, pulmonary, and other formulas, which primarily include
immune-enhancing & wound-healing formulas and formulas for critical care.
On the basis of stage, the Enteral Feeding Formulas Market is segmented into
adults and pediatrics.
On the basis of application, the market is segmented into
oncology, gastroenterology, neurology, diabetes, critical care, and other
applications. Other applications primarily include diseases and disorders of
the heart, renal system, lungs, and liver, along with psychiatric disorders. By
end user, the Enteral Feeding Formulas Market is segmented into hospitals and
long-term care facilities. Long-term care facilities are further segmented into
homecare agencies & hospices and nursing homes and assisted living
facilities.
The
Sample Report For This Report@
The market in North America and Europe is growing at a
significant rate owing to the rising geriatric population along with increasing
incidences of chronic diseases and disorders, increasing healthcare
expenditure, and increasing demand for homecare in these regions. The
Asia-Pacific region however is expected to become the growth center for the Enteral
Feeding Formulas Market.
The market in Japan, China, and India is likely to witness
significant growth during the forecast period, owing to the presence of a large
patient pool for chronic diseases and disorders, high incidences of preterm
births, growing healthcare expenditure, rapidly developing healthcare
infrastructure, increasing per capita income, growing middle-class population,
and growing population in these countries.
Some of the prominent players in the global Enteral Feeding
Formulas Market are Abbott Laboratories
(U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG
(Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG
(Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co.,
Ltd. (Japan), and Global Health Product Inc. (U.S.).
Get The
PDF Brochure For This Report@
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B
research on 30,000 high growth niche opportunities/threats which will impact
70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers
worldwide including 80% of global Fortune 1000 companies as clients. Almost
75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets™ are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and its
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s flagship competitive
intelligence and market research platform, "RT" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
No comments:
Post a Comment